DK1334119T3 - Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet - Google Patents

Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet

Info

Publication number: DK1334119T3
Authority: DK; Denmark
Prior art keywords: motif; rsv infection; rsv; immunity; compositions
Prior art date: 2000-10-18

Application number

DK01987765T

Other languages

English (en)

Other versions

DK1334119T4 (da

Inventor

Ralph A Tripp

Les Jones

Larry J Anderson

Original Assignee

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-18

Filing date

2001-10-18

Publication date

2009-02-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22911027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1334119(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-10-18 Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv

2009-02-23 Application granted granted Critical

2009-02-23 Publication of DK1334119T3 publication Critical patent/DK1334119T3/da

2019-03-18 Publication of DK1334119T4 publication Critical patent/DK1334119T4/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK01987765.3T 2000-10-18 2001-10-18 Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet DK1334119T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24152100P	2000-10-18	2000-10-18
PCT/US2001/032459 WO2002032942A2 (en)	2000-10-18	2001-10-18	Compositions and methods for modulating rsv infection and immunity

Publications (2)

Publication Number	Publication Date
DK1334119T3 true DK1334119T3 (da)	2009-02-23
DK1334119T4 DK1334119T4 (da)	2019-03-18

Family

ID=22911027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01987765.3T DK1334119T4 (da)	2000-10-18	2001-10-18	Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet

Country Status (9)

Country	Link
US (4)	US20040009177A1 (da)
EP (1)	EP1334119B2 (da)
AT (1)	ATE412666T1 (da)
AU (2)	AU2002224416A1 (da)
CA (1)	CA2426312C (da)
DE (1)	DE60136381D1 (da)
DK (1)	DK1334119T4 (da)
ES (1)	ES2316487T5 (da)
WO (1)	WO2002032942A2 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2006023029A2 (en) *	2004-06-16	2006-03-02	The Johns Hopkins University	The cysteine-rich region of respiratory syncytial virus and methods of use therefor
KR20080113223A (ko) *	2006-03-06	2008-12-29	심포젠 에이/에스	호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
CN101679513A (zh) *	2007-03-06	2010-03-24	西福根有限公司	用于治疗呼吸道合胞病毒感染的重组抗体
NZ585589A (en) *	2007-10-25	2012-07-27	Trellis Bioscience Inc	Anti-rsv g protein antibodies
GB0724253D0 (en) *	2007-12-12	2008-01-30	Fermentas Uab	Transfection reagent
SG190562A1 (en) *	2008-04-18	2013-06-28	Vaxinnate Corp	Deletion mutants of flagellin and methods of use
US20110318376A1 (en) *	2008-12-24	2011-12-29	University Of Rochester	Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins
US8846056B2 (en)	2009-08-04	2014-09-30	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control	Anti-RSV immunogens and methods of immunization
GB0917792D0 (en) *	2009-10-12	2009-11-25	Fermentas Uab	Delivery agent
US9856456B2 (en)	2009-10-12	2018-01-02	Thermo Fisher Scientific Baltics Uab	Delivery agent
EP2590675B1 (en)	2010-07-07	2018-08-29	Artificial Cell Technologies, Inc.	Respiratory syncytial virus antigenic compositions and methods
BR112013001937A2 (pt) *	2010-07-28	2016-05-24	Nissan Motor	eletrodo bipolar, bateria secundária bipolar utilizando o mesmo e método de fabricação de eletrodo bipolar
WO2014019718A1 (en)	2012-08-01	2014-02-06	Bavarian Nordic A/S	Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
EP2993009A1 (de) *	2014-09-08	2016-03-09	HILTI Aktiengesellschaft	Verfahren zur Steuerung eines Wandsägesystems beim Erstellen eines Trennschnittes
SE539731C2 (sv)	2016-03-04	2017-11-14	Vertical Wind Ab	Rotor för en elektrisk generator och förfarande för dess tillverkning
WO2019075400A1 (en) *	2017-10-13	2019-04-18	Trellis Bioscience, Llc	CONFORMATIONAL EPITOPES IN A CENTRAL PROTECTED REGION OF SYNCYTIAL RESPIRATORY VIRUS PROTEIN G
JP2021534239A (ja)	2018-08-08	2021-12-09	トレリス・バイオサイエンス，エルエルシー	Ｒｓｖの改善された受動的および能動的ワクチン
US11201095B1 (en)	2019-08-23	2021-12-14	Xilinx, Inc.	Chip package having a cover with window
US20230110614A1 (en) *	2020-03-23	2023-04-13	Atossa Therapeutics, Inc.	Heparin and n-acetylcysteine for the treatment of a respiratory virus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2718452B1 (fr)	1994-04-06	1996-06-28	Pf Medicament	Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
CA2198279A1 (en)	1994-08-25	1996-02-29	Johannes Petrus Maria Langedijk	Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection
EP0876487B1 (en) †	1996-01-24	2008-03-12	Schering Corporation	Mammalian cx3c chemokine genes
AUPO026596A0 (en) *	1996-06-05	1996-06-27	Biomolecular Research Institute Limited	Viral peptide
US6020182A (en) *	1996-07-12	2000-02-01	Connaught Laboratories Limited	Subunit respiratory syncytial virus vaccine preparation
EP1010692A1 (en)	1997-07-04	2000-06-21	Chisso Corporation	Liquid-crystal compounds having large value of permittivity anisotropy, liquid-crystal composition containing the same, and liquid-crystal display element made using the liquid-crystal composition
ES2236946T3 (es) *	1997-09-19	2005-07-16	Wyeth Holdings Corporation	Peptidos derivados de la proteina de union (g) del virus respiratorio sincitial.
FR2827605B1 (fr)	2001-07-20	2004-07-16	Pf Medicament	Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin

2001
- 2001-10-18 AT AT01987765T patent/ATE412666T1/de not_active IP Right Cessation
- 2001-10-18 CA CA2426312A patent/CA2426312C/en not_active Expired - Lifetime
- 2001-10-18 ES ES01987765T patent/ES2316487T5/es not_active Expired - Lifetime
- 2001-10-18 WO PCT/US2001/032459 patent/WO2002032942A2/en not_active Ceased
- 2001-10-18 DK DK01987765.3T patent/DK1334119T4/da active
- 2001-10-18 AU AU2002224416A patent/AU2002224416A1/en not_active Abandoned
- 2001-10-18 DE DE60136381T patent/DE60136381D1/de not_active Expired - Lifetime
- 2001-10-18 EP EP01987765.3A patent/EP1334119B2/en not_active Expired - Lifetime
2003
- 2003-04-18 US US10/420,387 patent/US20040009177A1/en not_active Abandoned
2005
- 2005-05-26 US US11/139,372 patent/US8173131B2/en not_active Expired - Fee Related
2009
- 2009-03-12 AU AU2009200997A patent/AU2009200997B2/en not_active Expired
2012
- 2012-01-25 US US13/358,320 patent/US8778354B2/en not_active Expired - Fee Related
2014
- 2014-04-15 US US14/252,836 patent/US20140288267A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US8173131B2 (en)	2012-05-08
WO2002032942A2 (en)	2002-04-25
US20120258111A1 (en)	2012-10-11
ATE412666T1 (de)	2008-11-15
EP1334119A2 (en)	2003-08-13
AU2009200997B2 (en)	2011-12-22
US20060018925A1 (en)	2006-01-26
ES2316487T3 (es)	2009-04-16
EP1334119B2 (en)	2018-11-28
AU2009200997A1 (en)	2009-04-02
EP1334119B1 (en)	2008-10-29
CA2426312C (en)	2014-01-14
DK1334119T4 (da)	2019-03-18
AU2002224416A1 (en)	2002-04-29
ES2316487T5 (es)	2019-05-13
DE60136381D1 (de)	2008-12-11
US20140288267A1 (en)	2014-09-25
US8778354B2 (en)	2014-07-15
US20040009177A1 (en)	2004-01-15
CA2426312A1 (en)	2002-04-25
WO2002032942A3 (en)	2002-12-12

Publication	Publication Date	Title
DK1334119T3 (da)	2009-02-23	Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet
ATE327246T1 (de)	2006-06-15	Hepatitis c tripeptid inhibitoren
MY138860A (en)	2009-08-28	Hiv protease inhibitors.
DK1644363T3 (da)	2012-05-29	Triheterocykliske forbindelser, sammensætninger og fremgangsmåder til behandling af cancer eller virussygdomme
IS7533A (is)	2004-11-16	Lifrarbólgu C-veirutálmar
DE60334205D1 (en)	2010-10-28	Heterocyclische sulfonamid-hepatitis-c-virus-hemmer
ATE310089T1 (de)	2005-12-15	Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
ATE413411T1 (de)	2008-11-15	Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
DK1301201T3 (da)	2007-04-02	Behandling af glycogenosis type II
DK1479691T3 (da)	2007-03-12	Langvarigt aktive fuionspeptidinhibitorer for HIV infektion
DK0517986T3 (da)	1998-03-30	Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater
MXPA02007271A (es)	2004-07-30	Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales.
DE60137146D1 (de)	2009-02-05	Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
EA200700976A1 (ru)	2007-12-28	Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
IS5956A (is)	2001-05-30	Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla
DE60236443D1 (de)	2010-07-01	Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie
EP1546415A4 (en)	2006-01-11	ANTI-TSG101 ANTIBODIES AND USES THEREOF FOR TREATING VIRAL INFECTIONS
WO2006109174A3 (en)	2008-01-03	Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid
WO2003017943A3 (en)	2005-01-13	Therapeutic compositions and methods for treating viral infection
DK1778271T3 (da)	2009-02-16	Peptid til behandling af herpesvirusinfektioner
ATE237616T1 (de)	2003-05-15	Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv
ATE408421T1 (de)	2008-10-15	Pna-konjugat zur therapie von mit hiv in zusammenhang stehenden erkrankungen
WO2003008410A8 (en)	2004-04-01	Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression
DE69932741D1 (de)	2006-09-21	Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DK0470144T3 (da)	1995-10-02	D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer